HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bing Xu Selected Research

N- (1- ((6- fluoro- 2- naphthyl)methyl)pyrrolidin- 3- yl)- 2- (1- ((3- methyl- 1- oxidopyridin- 2- yl)carbonyl)piperidin- 4- ylidene)acetamide

1/2019The small molecular CCR3 antagonist YM344031 attenuates neurodegenerative pathologies and improves learning and memory performance in a mouse model of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bing Xu Research Topics

Disease

158Neoplasms (Cancer)
10/2022 - 01/2002
36Leukemia
05/2022 - 08/2003
36Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2022 - 08/2003
28Inflammation (Inflammations)
07/2022 - 10/2006
19Neoplasm Metastasis (Metastasis)
05/2022 - 02/2002
17Infections
05/2022 - 12/2003
16Stomach Neoplasms (Stomach Cancer)
10/2022 - 06/2014
16Breast Neoplasms (Breast Cancer)
12/2020 - 02/2007
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2021 - 10/2003
13Carcinogenesis
01/2021 - 01/2002
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 12/2014
11Pain (Aches)
05/2022 - 05/2014
10Hepatocellular Carcinoma (Hepatoma)
11/2020 - 07/2015
9Lymphoma (Lymphomas)
08/2022 - 12/2014
9Carcinoma (Carcinomatosis)
01/2022 - 01/2007
9Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 11/2003
9BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2021 - 08/2003
8Wounds and Injuries (Trauma)
11/2021 - 09/2005
8Body Weight (Weight, Body)
03/2021 - 05/2008
8Colorectal Neoplasms (Colorectal Cancer)
05/2019 - 05/2010
7Hypoxia (Hypoxemia)
07/2022 - 10/2007
7Alzheimer Disease (Alzheimer's Disease)
05/2022 - 04/2013
7Colitis
04/2021 - 01/2016
6Ischemic Stroke
11/2022 - 01/2019
6Heart Failure
10/2021 - 09/2016
6Fibrosis (Cirrhosis)
04/2021 - 07/2012
6Necrosis
03/2021 - 04/2009
6Ischemia
01/2020 - 04/2010
5Myocardial Infarction
10/2022 - 01/2019
5Esophageal Squamous Cell Carcinoma
10/2021 - 06/2017
5Alcoholism (Alcohol Abuse)
07/2021 - 04/2010
5Hemorrhage
01/2021 - 12/2003
5Osteoporosis
02/2020 - 06/2009
5Lung Injury
01/2015 - 05/2006
4Heart Diseases (Heart Disease)
10/2022 - 09/2014
4Retinoblastoma (Glioblastoma, Retinal)
01/2022 - 02/2012

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2002
31Pharmaceutical PreparationsIBA
08/2022 - 08/2003
27EnzymesIBA
01/2021 - 02/2007
24Peptides (Polypeptides)IBA
01/2022 - 01/2014
19Biological ProductsIBA
08/2022 - 01/2002
18CytokinesIBA
05/2022 - 10/2007
13Therapeutic UsesIBA
02/2022 - 10/2003
12Biomarkers (Surrogate Marker)IBA
11/2022 - 04/2011
11Long Noncoding RNAIBA
01/2022 - 10/2016
10RNA (Ribonucleic Acid)IBA
03/2022 - 04/2009
9N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
05/2022 - 01/2015
9MicroRNAs (MicroRNA)IBA
11/2020 - 11/2012
9Small Interfering RNA (siRNA)IBA
01/2020 - 01/2012
8LipopolysaccharidesIBA
07/2022 - 05/2006
8LigandsIBA
01/2021 - 12/2014
8Cadherins (E-Cadherin)IBA
01/2021 - 01/2002
7Cisplatin (Platino)FDA LinkGeneric
10/2022 - 07/2015
7triptolideIBA
04/2022 - 05/2010
7DNA (Deoxyribonucleic Acid)IBA
03/2022 - 12/2003
7CollagenIBA
01/2022 - 06/2004
7Messenger RNA (mRNA)IBA
01/2021 - 05/2006
7HydrogelsIBA
01/2017 - 09/2005
6Oxygen (Dioxygen)IBA
11/2022 - 05/2002
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 05/2010
6LipidsIBA
01/2022 - 03/2012
6Disulfiram (Antabuse)FDA Link
07/2021 - 04/2010
6AntigensIBA
01/2021 - 10/2003
6Tyrosine (L-Tyrosine)FDA Link
01/2021 - 12/2013
6CateninsIBA
10/2020 - 01/2002
6Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2019 - 07/2014
6Doxorubicin (Adriamycin)FDA LinkGeneric
07/2019 - 12/2011
5Adenosine Triphosphate (ATP)IBA
06/2022 - 03/2015
5apatinibIBA
05/2022 - 01/2018
5AcidsIBA
01/2022 - 07/2006
5Imatinib Mesylate (Gleevec)FDA Link
12/2021 - 08/2003
5Histone Deacetylase InhibitorsIBA
09/2021 - 01/2015
5CopperIBA
07/2021 - 04/2010
5disulfiram-copperIBA
07/2021 - 04/2010
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 05/2006
5Interleukin-6 (Interleukin 6)IBA
04/2021 - 05/2006
5Fibronectins (Fibronectin)IBA
04/2021 - 01/2015
5CalciumIBA
01/2021 - 07/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2013
5Insulin (Novolin)FDA Link
10/2020 - 09/2013
5CholesterolIBA
03/2020 - 03/2012
5Prednisone (Sone)FDA LinkGeneric
02/2020 - 08/2003
5Biocompatible Materials (Biomaterials)IBA
01/2020 - 09/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2009
5DipeptidesIBA
01/2020 - 12/2011
5PlatinumIBA
01/2019 - 01/2016
5Cytarabine (Cytosar-U)FDA LinkGeneric
01/2013 - 08/2003
4Circular RNAIBA
10/2022 - 10/2020
4SteroidsIBA
01/2022 - 01/2019
4Proteasome InhibitorsIBA
01/2022 - 11/2018
4ChromatinIBA
01/2022 - 05/2004
4PhosphopeptidesIBA
01/2022 - 01/2020
4Bortezomib (Velcade)FDA Link
01/2022 - 11/2018

Therapy/Procedure

67Therapeutics
06/2022 - 06/2002
19Drug Therapy (Chemotherapy)
02/2022 - 09/2003
12Hematopoietic Stem Cell Transplantation
01/2022 - 11/2003
10Transplantation
10/2022 - 12/2003
8Radiotherapy
01/2022 - 01/2011
7Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2021 - 10/2014
5Immunotherapy
03/2020 - 11/2016